banner2013d

Publications

  • Keyao Pan, Jinxue Long, Haoxin Sun, Gregory J. Tobin, Peter L. Nara, Michael W. Deem
    Selective Pressure to Increase Charge in Immunodominant Epitopes of the H3 Hemagglutinin Influenza Protein
    J Mol Evol. 2011 January; 72(1): 90–103. Published online 2010 November 18.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033527/?tool=pmcentrez

  • Wolfram JH, Nara PL. Exchange and sharing of new information, experiences, and approaches to controlling, reducing, and eventually eradicating different types of diseases. Conclusion. Vaccine. 2010 Oct 1;28 Suppl 5:F85-8. No abstract available.
    http://www.ncbi.nlm.nih.gov/pubmed/20891047  

  • Wolfram JH, Nara PL.
    Brucellosis as a Transboudary Infection of Animals and Humans which Needs to be Managed by Cooperative Efforts of Different Countries. Introduction. Vaccine. 2010 Oct 1;28 Suppl 5:F1-2.
    http://www.ncbi.nlm.nih.gov/pubmed/20850687

  • Eguchi-Ogawa T, Wertz N, Sun XZ, Puimi F, Uenishi H, Wells K, Chardon P, Tobin GJ, Butler JE.
    Antibody repertoire development in fetal and neonatal piglets. XI. The relationship of variable heavy chain gene usage and the genomic organization of the variable heavy chain locus.
    J Immunol. 2010 Apr 1;184(7):3734-42. Epub 2010 Mar 5    .
    http://www.ncbi.nlm.nih.gov/pubmed/20207992

    •
  • Sponseller BA, Strait E, Jergens A, Trujillo J, Harmon K, Koster L, Jenkins-Moore M, Killian M, Swenson S, Bender H, Waller K, Miles K, Pearce T, Yoon KJ, Nara P. Influenza A pandemic (H1N1) 2009 virus infection in domestic cat.
    Emerg Infect Dis. 2010 Mar;16(3):534-7.
    http://www.ncbi.nlm.nih.gov/pubmed/20202440

  • Tobin GJ, Trujillo JD, Bushnell RV, Lin G, Chaudhuri AR,Long J, Barrera J, Pena L, Grubman, MJ and Nara PL.
    Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199, 2008.
    http://www.ncbi.nlm.nih.gov/pubmed/18852005

    •
  • Nara PL, Nara D, Chaudhuri AR, Lin G, and Tobin GJ
    Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: Not missing the opportunities. Vaccine 26:6200-6211, 2008.
    http://www.ncbi.nlm.nih.gov/pubmed/18708109

    •
  • Gay CG, Richie TL, Pastoret PP, Minguez-Tudela I, de Baetselier P, Göbel T, Goddeeris B, Kaiser P, Morrison I, Sánchez-Vizcaíno JM, Anderson K, Baillie LW, Brown WC, Estes DM, Herrera E, Nara PL, Ockenhouse CF, Roth JA, Sztein MB.    Advances in immunology and vaccine discovery report of the United States-European Commission workshop.
    Vaccine. 2007 Oct 10;25(41):7007-11. Epub 2007 Aug 6.
    http://www.ncbi.nlm.nih.gov/pubmed/17728022

  • Nara PL. The status and role of vaccines in the U.S. food animal industry. Implications for biological terrorism.
    Ann N Y Acad Sci. 1999;894:206-17. Review.
    http://www.ncbi.nlm.nih.gov/pubmed/10681992

  • Kohler H, Muller S, Schiffer M, Nara PL. Few clues for AIDS vaccines from structural data on gp120 and its receptors and antibodies
    J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):315-6.
    http://www.ncbi.nlm.nih.gov/pubmed/10077183

    •
  • Garrity RR, Rimmelzwaan G, Minassian A, Tsai WP, Lin G, de Jong JJ, Goudsmit J, Nara PL. Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.
    J Immunol. 1997 Jul 1;159(1):279-89.
    http://www.ncbi.nlm.nih.gov/pubmed/9200464

For further information, please contact: Dr. Gregory J. Tobin:  tobin@bmi-md.com

Research & Development

dreamstime_1958257Our Research & Development (R&D) includes human applications such as HIV & Aids, Respiratory Agents (Influenza Virus, Rhinovirus), and Non-typeable Haemophilus Influenza (NTHI). Our veterinary applications include Foot and Mouth Disease Virus (FMDV), Infectious Pancreatic Necrosis Virus (IPNV), and Porcine Reporductive & Respiratory Syndrome Virus (PRRS). You'll find more information on these topics by going to our main Research & Development page.

Company News

blk triangleFall 2012: BMI has been awarded a contract from the Henry M. Jackson Foundation for the Advancement of Military Medicine.
blk triangleSpring 2012: BMI announces award of a grant from the Bill and Melinda Gates Foundation Grand Challenges Exploration Poliovirus Eradication program.
blk triangleJune 2011: BMI announces collaborative research agreement with Crucell-BV for development of a universal influenza vaccine
blk triangleNov. 2010: BMI announces collaborative research agreement with GSK-Biologicals for development of an immune refocused vaccine for respiratory infection
blk triangleSept 2010: BMI is awarded a Qualifying Therapeutic Discovery Project Award
blk triangleJune 2010: BMI is awarded a Small Business Innovative Research Grant from the NIH for vaccine development
blk triangleNov. 2009: BMI is a prime contractor in the Fundamentals of Biology Program of DARPA/DSO for the study of modularity in biological systems